Polyrizon Ltd. (NASDAQ:PLRZ) Short Interest Update

Polyrizon Ltd. (NASDAQ:PLRZ) saw a significant growth in short interest during the month of September. As of September 15th, there was short interest totaling 755,100 shares, a growth of 478.2% from the August 31st total of 130,600 shares. Based on an average daily volume of 6,040,000 shares, the days-to-cover ratio is currently 0.1 days. Based on an average daily volume of 6,040,000 shares, the days-to-cover ratio is currently 0.1 days.

Hedge Funds Weigh In On Polyrizon

An institutional investor recently bought a new position in Polyrizon stock. Citadel Advisors LLC bought a new stake in shares of Polyrizon Ltd. (NASDAQ:PLRZ) during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund bought 38,337 shares of the company’s stock, valued at approximately $83,000. Citadel Advisors LLC owned approximately 0.91% of Polyrizon at the end of the most recent quarter.

Polyrizon Stock Performance

PLRZ stock opened at $1.09 on Friday. Polyrizon has a fifty-two week low of $0.55 and a fifty-two week high of $1,200.00. The business’s 50 day moving average price is $1.11 and its two-hundred day moving average price is $33.59.

Wall Street Analysts Forecast Growth

Separately, Wall Street Zen upgraded shares of Polyrizon from a “strong sell” rating to a “hold” rating in a report on Saturday, September 20th.

Polyrizon Company Profile

Polyrizon Ltd. is a development stage biotech company specializing in the development of medical device hydrogels delivered in the form of nasal sprays. Polyrizon Ltd. is based in Raanana, Israel.